RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @JACCJournals: New #CME, #MOC, #ECME content from #JACCBTS! Read "SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in th…
RT @ICH_Nephro: Cardioprotective effects of #SGLT2 inhibitors in #diabetic and non-diabetic #heart. Collaborative study between Hatter Inst…
Cardioprotective effects of #SGLT2 inhibitors in #diabetic and non-diabetic #heart. Collaborative study between Hatter Institute @UCL_ICS and @ICH_Nephro @UCLchildhealth published in @JACCJournals. https://t.co/BcbPAJ9yTe https://t.co/eaYITyoIYY